Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Che Young Lee

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2025
Engineered suppressor T cells overexpressing IFN-α and PD-L1 inhibit GVHD but retain GVL effects in miceYuanyuan Tian, Bei Jia, Che Young Lee, et al.
Journal of Cancer Survivorship : Research and Practice|May 27, 2024
Outcomes for breast cancer survivors with metastatic disease in a physical activity program for medically underserved cancer survivorsChe Young Lee, Kylee Laffoon, Scherezade K Mama, et al.
Journal of Cancer Survivorship : Research and Practice|March 13, 2024
Optimization of mHealth behavioral interventions for patients with chronic lymphocytic leukemia: the HEALTH4CLL studyChe Young Lee, Max J Gordon, Melissa M Markofski, et al.
Journal of the National Cancer Institute|April 30, 2024
Expanding active living after cancer to underserved cancer survivors and their caregiversScherezade K Mama, Stacy J Mitchell, Patricia V Tracy, et al.
Blood|October 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2025
Engineered suppressor T cells overexpressing IFN-α and PD-L1 inhibit GVHD but retain GVL effects in miceYuanyuan Tian, Bei Jia, Che Young Lee, et al.
Journal of Cancer Survivorship : Research and Practice|May 27, 2024
Outcomes for breast cancer survivors with metastatic disease in a physical activity program for medically underserved cancer survivorsChe Young Lee, Kylee Laffoon, Scherezade K Mama, et al.
Journal of Cancer Survivorship : Research and Practice|March 13, 2024
Optimization of mHealth behavioral interventions for patients with chronic lymphocytic leukemia: the HEALTH4CLL studyChe Young Lee, Max J Gordon, Melissa M Markofski, et al.
Journal of the National Cancer Institute|April 30, 2024
Expanding active living after cancer to underserved cancer survivors and their caregiversScherezade K Mama, Stacy J Mitchell, Patricia V Tracy, et al.
Blood|October 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.
Pageof 2